Confluence Pharmaceuticals' Convertible Note Round

Confluence Pharmaceuticals raised a round of funding on October 04, 2018.

Confluence Pharmaceuticals is developing therapeutic medications for neurological development disorders. The company's focus is advancing a drug discovery that improves social and communication impair…

Articles about Confluence Pharmaceuticals' Convertible Note Round: